Switch to
View more

Parnax Lab Ltd

PARNAXLAB
Health CarePharmaceuticals
SmallcapWith a market cap of ₹113 cr, stock is ranked 2,044
High RiskStock is 4.05x as volatile as Nifty
100.000.80 (+0.81%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹113 cr, stock is ranked 2,044
High RiskStock is 4.05x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
13.84
PB RatioPB Ratio
3.49
Dividend YieldDiv. Yield
Sector PESector PE
38.54
Sector PBSector PB
4.86
Sector Div YldSctr Div Yld
0.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Parnax Lab is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations

Financial TrendFinancial statements 

2019202020212022110.8995.9790.27163.363.30-2.92-0.378.23
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has increased by 4.99%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events